Neurosteroids in PTSD - Biomarkers to Therapeutics

The goal of this project is to conduct a randomized controlled trial in OEF/OIF/OND Veterans with PTSD to determine if adjunctive DHEA improves PTSD symptoms. Neurosteroid profiles will be quantified by mass spectrometry at baseline and post-treatment to investigate biomarker candidates of therapeutic response.

Awarded By

  • VA Career Development Award to Steven Szabo, MD



  • July 2018 - June 2023